Temporal limits of therapeutic hypothermia onset in clinical trials for acute ischemic stroke: How early is early enough?

Brain Circulation
Hangil Lee, Yuchuan Ding

Abstract

Stroke is one of the leading causes of mortality and morbidity worldwide, and yet, current treatment is limited to thrombolysis through either t-PA or mechanical thrombectomy. While therapeutic hypothermia has been adopted in clinical contexts such as neuroprotection after cardiac resuscitation and neonatal hypoxic-ischemic encephalitis, it is yet to be used in the context of ischemic stroke. The lack of ameliorative effect in ischemic stroke patients may be tied to the delayed cooling induction onset. In the trials where the cooling was initiated with significant delay (mostly systemic cooling methods), minimal benefit was observed; on the other hand, when cooling was initiated very early (mostly selective cooling methods), there was significant efficacy. Another timing factor that may play a role in amelioration may be the onset of cooling relative to thrombolysis therapy. Current understanding of the pathophysiology of acute ischemic injury and ischemia-reperfusion injury suggests that hypothermia before thrombolysis may be the most beneficial compared to cooling initiation during or after reperfusion. As many of the systemic cooling methods tend to require longer induction periods and extensive, separate procedures from thr...Continue Reading

References

Sep 1, 1970·Journal of Neurosurgery·K Sourek, V Trávnícek
Apr 10, 2004·Stroke; a Journal of Cerebral Circulation·Derk W Krieger, Midori A Yenari
Mar 3, 2009·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Sheryl Martin-SchildJames C Grotta
Aug 21, 2010·Stroke; a Journal of Cerebral Circulation·Thomas M HemmenUNKNOWN ICTuS-L Investigators
Feb 2, 2012·Current Treatment Options in Neurology·Rainer Kollmar, Stefan Schwab
Jun 1, 2012·The New England Journal of Medicine·Seetha ShankaranUNKNOWN Eunice Kennedy Shriver NICHD Neonatal Research Network
Oct 31, 2012·International Journal of Molecular Sciences·Jens MinnerupChristoph Kleinschnitz
Jan 18, 2014·Stroke; a Journal of Cerebral Circulation·Katja PiironenMarkku Kaste
Jun 21, 2016·Neurological Research·Kaiyin LiuYuchuan Ding
Nov 12, 2016·Stroke; a Journal of Cerebral Circulation·Patrick LydenUNKNOWN Collaborators
Aug 24, 2017·Neuropharmacology·Kota Kurisu, Midori A Yenari
Apr 26, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Meng-Yu WuChia-Jung Li
Jul 19, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Chuanjie WuXunming Ji
Apr 30, 2019·Neurological Research·Yun HanXiaokun Geng
Dec 21, 2019·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Longfei WuXunming Ji
Dec 31, 2019·Stroke; a Journal of Cerebral Circulation·Yunxia DuanXunming Ji
May 20, 2020·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·Thomas W LinkAthos Patsalides

❮ Previous
Next ❯

Citations

Mar 9, 2021·Frontiers in Physiology·Fabrice BertileSylvain Giroud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.